NEU 3.16% $13.18 neuren pharmaceuticals limited

Angelman trial

  1. 1,242 Posts.
    lightbulb Created with Sketch. 317
    I asked specifically about the Angelman trial and Jon confirmed it's indeed completed. However, he is still guiding Q3 result
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.